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We read with interest the recent report from Spain [1] and
would like to report the presentation and management of
patients with H1N1 on our intensive care unit.
As of September 2009, over 254,000 people have been
affected worldwide with at least 2,800 deaths. The UK has
one of the highest numbers of confirmed cases in Europe [2].
Between June and September 2009, there were 78 con-
firmed cases of H1N1 flu admitted to Birmingham Heartlands
Hospital. These patients were predominantly young (median
30.5 years, interquartile range 23 to 53) and female (79.5%);
10 (16%) patients were pregnant, 19 (24.3%) patients had
chronic lung disease and 24 (30.8%) patients had no
underlying medical problems.
Seven patients (three male, four female) developed rapidly
progressive respiratory failure and required intensive care
admission. Compared with the Spanish study, our patients
were similarly young (median age 35 years, interquartile range
30 to 48). Four out of seven patients were of ethnic minority.
The presentation was similar, with fever (n = 7), respiratory
symptoms (n = 7), flu-like illness (n = 5), gastrointestinal upset
(n = 2) and confusion (n = 1). Co-morbidities included obesity
(body mass index 30 to 35, n = 3), chronic respiratory illness
(n = 2), ischaemic heart disease (n = 2) and diabetes mellitus
(n = 1). These seven patients’ Acute Physiology and Chronic
Health Evaluation II scores were higher, with a mean of 16
(standard deviation 2), and they had a predicted mortality of
35 (standard deviation 26). Chest X-ray scans of critically ill
patients started with mild changes but rapidly developed
bilateral changes consistent with acute respiratory distress
syndrome (ARDS). Only one patient developed multiorgan
failure requiring vasopressors and haemofiltration.
Profound hypoxaemia was evident in all patients despite them
having normal lung compliance and receiving mechanical
ventilation. Airway pressure release ventilation was used on
five patients with no significant benefit. Two patients required
transfer for venovenous extracorporeal membrane oxygena-
tion (ECMO) at ventilation days 16 and 17 due to refractory
hypoxaemia. In contrast to previous reports [3,4], pulmonary
embolism was not a feature. Paralytic ileus was common and
double dosages of antiviral treatment were administered to
ensure absorption. Six patients were alive on discharge and
one patient (with significant premorbid co-morbidities) did not
survive, giving a 28-day mortality of 14.3%.
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ARDS = acute respiratory distress syndrome; ECMO = extracorporeal membrane oxygenation.
Authors’ response
Jordi Rello and Alejandro Rodríguez, for the H1N1 SEMICYUC Working Group
We appreciate the interest from Dr Yeung and colleagues in
our article and their insightful observations regarding manage-
ment of severe influenza A (H1N1)v. The observed intensive
care unit mortality (14.3%) described by Yeung and colleagues
is similar to previous reports [5,6]. In our study the mortality
rate was 30%; 75% of patients required mechanical ventila-
tion due to severe hypoxemia, and 33% of them required the
prone position [1]. ECMO, however, was not available.
The impact of ECMO on survival of patients with ARDS
remains controversial. In a recent study in patients with
influenza (H1N1) and ARDS treated with ECMO, the mortalityCritical Care    Vol 13 No 6 Yeung et al.
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was 23% [7]. This rate is higher than the mortality reported in
patients with ARDS without ECMO (9%), but is significantly
lower than that reported with the use of ECMO for ARDS due
to heterogeneous aetiology (30 to 48%). Recent evidence
suggests using ECMO may be a cost-effective strategy for
management of ARDS patients [8]. The impact of ECMO on
mortality in severe respiratory failure by influenza A may be
associated with the specific population included (young
people with ARDS secondary to viral pneumonia). Which
advanced respiratory rescue technique, such as ECMO or
high-frequency oscillation, is preferred should be further
assessed by randomized controlled trial.
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